June 19, 2026 a 07:43 pm
WST: Fundamental Ratio Analysis - West Pharmaceutical Services, Inc.
The stock of West Pharmaceutical Services, Inc. (WST) presents a strong position in the healthcare sector, specifically in the medical instruments and supplies industry. With a broad global distribution network, it plays a pivotal role in the containment and delivery solutions for injectable pharmaceuticals. Its two main business units offer a diverse range of advanced products and services, which cater to a wide array of healthcare needs worldwide.
Fundamental Rating
The fundamental analysis of WST reveals a solid performance with a rating of B+. The scores reflect strength in return on equity and return on assets, though there's room for improvement in valuation metrics like price-to-earnings and price-to-book ratios.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
Historical data reveals consistency in key performance metrics with room for improvement in overall score.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | 3 | 3 | 5 | 5 | 3 | 1 | 1 |
| Previous | 0 | 3 | 5 | 5 | 3 | 1 | 1 |
Analyst Price Targets
Analyst consensus suggests potential upside, with a high target of $400, low of $295, and a median of $317.5.
| High | Low | Median | Consensus |
|---|---|---|---|
| $400 | $295 | $317.5 | $330.83 |
Analyst Sentiment
Market sentiment remains positive with a "Buy" consensus predominately supported by 11 buy recommendations.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 11 | |
| Hold | 3 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
West Pharmaceutical Services, Inc. presents a balanced opportunity for potential investors with strong fundamentals in profitability measures such as ROE and ROA, while valuation metrics could improve. Despite economic uncertainties, analyst price targets suggest a generally favorable outlook in the medium term. The company's strategic position in essential healthcare products underpins its long-term growth prospects. Consequently, the stock could be a viable addition for those seeking to bolster their healthcare-focused portfolios, albeit with mindful consideration of current valuation impacts.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years